The substitution of arginine for glycine 85 of the alpha 1(I) procollagen chain results in mild osteogenesis imperfecta. The mutation provides direct evidence for three discrete domains of cooperative melting of intact type I collagen.
We report a case of mild osteogenesis imperfecta in a 56-year-old male undergoing aortic valve replacement surgery. The primary defect in this patient was the substitution of arginine for glycine 85 in one of the two chains of alpha 1(I) procollagen. The thermal stability of the type I collagen synthesized by the patient's cultured skin fibroblasts was examined by enzymatic digestion. Digestion of the mutant type I collagen with trypsin and chymotrypsin at increasing temperatures sequentially generated three discrete collagenous fragments, approximately 90, 170, and 230 amino acids shorter than normal type I collagen. This incremental thermal denaturation is indicative of cooperative melting blocks within the type I collagen. This is the first demonstration of such cooperative blocks of melting in intact, essentially normal post-translationally modified type I collagen. This direct evidence for cooperative melting domains of uncut type I collagen suggests that discrete blocks of amino acids function as core sites stabilizing the collagen helix. The location of mutations of the alpha chains of type I collagen relative to these discrete blocks of amino acids may influence the severity of the disease phenotype.
Deak
S B
SB
Department of Surgery, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick 08903.
Scholz
P M
PM
Amenta
P S
PS
Constantinou
C D
CD
Levi-Minzi
S A
SA
Gonzalez-Lavin
L
L
Mackenzie
J W
JW
D000595:Amino Acid Sequence; D001120:Arginine; D001483:Base Sequence; D015152:Blotting, Northern; D002478:Cells, Cultured; D004247:DNA / Q000235:genetics; D005347:Fibroblasts / Q000502:physiology; D005998:Glycine; D006801:Humans; D046911:Macromolecular Substances; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D009154:Mutation; D009838:Oligodeoxyribonucleotides; D010013:Osteogenesis Imperfecta / Q000235:genetics* / Q000473:pathology; D010449:Peptide Mapping; D016133:Polymerase Chain Reaction / Q000379:methods; D011347:Procollagen / Q000235:genetics*; D011487:Protein Conformation; D011499:Protein Processing, Post-Translational; D012313:RNA / Q000235:genetics / Q000302:isolation & purification; D012016:Reference Values; D015183:Restriction Mapping; D012867:Skin / Q000473:pathology / Q000503:physiopathology*; D012879:Skin Physiological Phenomena; D013816:Thermodynamics
D046911:Macromolecular Substances; D009838:Oligodeoxyribonucleotides; D011347:Procollagen; D012313:RNA; D004247:DNA; D001120:Arginine; D005998:Glycine